The University of Glasgow uses cookies for analytics. Find out more about our Privacy policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
Analytical cookies help us improve our website. We use Google Analytics. All data is anonymised.
Clarity helps us to understand our users’ behaviour by visually representing their clicks, taps and scrolling. All data is anonymised.
email:
Rosalinde.Poortvliet@glasgow.ac.uk
Walton Building, Glasgow Royal Infirmary, G31 2er
Stott, D. J. et al. (2017) Thyroid hormone therapy for older adults with subclinical hypothyroidism. New England Journal of Medicine, 376(26), pp. 2534-2544. (doi: 10.1056/NEJMoa1603825) (PMID:28402245)
Stott, D. J. et al. (2017) Study protocol; thyroid hormone replacement for untreated older adults with subclinical hypothyroidism - a randomised placebo controlled trial (TRUST). BMC Endocrine Disorders, 17, 6. (doi: 10.1186/s12902-017-0156-8) (PMID:28158982) (PMCID:PMC5291970)
Poortvliet, R. K.E. et al. (2016) Risk stratification and treatment effect of statins in secondary cardiovascular prevention in old age: additive value of N-terminal pro-B-type natriuretic peptide. European Journal of Preventive Cardiology, 23(10), pp. 1104-1113. (doi: 10.1177/2047487315617908) (PMID:26603744)
Poortvliet, R. K.E. et al. (2015) Biological correlates of blood pressure variability in elderly at high risk of cardiovascular disease. American Journal of Hypertension, 28(4), pp. 469-479. (doi: 10.1093/ajh/hpu181) (PMID:25298176)
Wijsman, L. W. et al. (2014) N-terminal pro-brain natriuretic peptide and cognitive decline in older adults at high cardiovascular risk. Annals of Neurology, 76(2), pp. 213-222. (doi: 10.1002/ana.24203)
Poortvliet, R.K.E. et al. (2012) Blood pressure variability and cardiovascular risk in the PROspective study of pravastatin in the elderly at risk (PROSPER). PLoS ONE, 7(12), e52438. (doi: 10.1371/journal.pone.0052438) (PMID:23285043) (PMCID:PMC3527505)
Stott, D. J. et al. (2017) Thyroid hormone therapy for older adults with subclinical hypothyroidism. New England Journal of Medicine, 376(26), pp. 2534-2544. (doi: 10.1056/NEJMoa1603825) (PMID:28402245)
Stott, D. J. et al. (2017) Study protocol; thyroid hormone replacement for untreated older adults with subclinical hypothyroidism - a randomised placebo controlled trial (TRUST). BMC Endocrine Disorders, 17, 6. (doi: 10.1186/s12902-017-0156-8) (PMID:28158982) (PMCID:PMC5291970)
Poortvliet, R. K.E. et al. (2016) Risk stratification and treatment effect of statins in secondary cardiovascular prevention in old age: additive value of N-terminal pro-B-type natriuretic peptide. European Journal of Preventive Cardiology, 23(10), pp. 1104-1113. (doi: 10.1177/2047487315617908) (PMID:26603744)
Poortvliet, R. K.E. et al. (2015) Biological correlates of blood pressure variability in elderly at high risk of cardiovascular disease. American Journal of Hypertension, 28(4), pp. 469-479. (doi: 10.1093/ajh/hpu181) (PMID:25298176)
Wijsman, L. W. et al. (2014) N-terminal pro-brain natriuretic peptide and cognitive decline in older adults at high cardiovascular risk. Annals of Neurology, 76(2), pp. 213-222. (doi: 10.1002/ana.24203)
Poortvliet, R.K.E. et al. (2012) Blood pressure variability and cardiovascular risk in the PROspective study of pravastatin in the elderly at risk (PROSPER). PLoS ONE, 7(12), e52438. (doi: 10.1371/journal.pone.0052438) (PMID:23285043) (PMCID:PMC3527505)